amcure, a spin-off from the Karlsruhe Institute of Technology.
  • Industry: Biotechnology
  • Founder: Matthias Klaften | Alexandra Matzke
  • Website:
  • Location: Leopoldshafen
  • Size: 1-10 employees
  • Overview: amcure, a spin-off from the Karlsruhe Institute of Technology, develops AM001 as first-in-class compound. AM001’s mode of action differs fundamentally from known experimental or approved compounds for the inhibition of angiogenesis and metastasis in cancer therapy, which in most cases either address only a single RTK or target multiple RTKs as broadband inhibitors. By its novel targeting strategy AM001 combines the advantages of receptor specificity and broadband inhibition. Application area for AM001 will be highly metastasizing cancer types with a focus on pancreatic cancer.

Search 1.5 billion
Email & Phone#

Browse to anyone's Linkedin profile, and Contactout will find that person's email address and phone number

Start your free trial
(300+ Reviews)

People also viewed these companies

  • Information Technology and Services
  • Renewables & Environment
  • Marketing and Advertising
  • Electrical/Electronic Manufacturing
  • Management Consulting
  • Entertainment